Search - tctmd.com

Displaying 461 - 480 of 769

Sort: Relevancy | Date

News Daily News

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR

August 25, 2015

News Daily News

Subanálisis del Ensayo CoreValve norteamericano: Solo la TAVR Femoral Ofrece una Ventaja en la Calidad de Vida Precoz sobre la Cirugía

L.A. McKeown

August 19, 2015

News Daily News

CoreValve美国亚组分析：仅有股动脉TAVR表现出相对于外科手术的早期生活质量优势

L.A. McKeown

August 19, 2015

News Daily News

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

L.A. McKeown

August 19, 2015

News Industry News

Sorin Group Obtains Health Canada Approval for Perceval, Its Next Generation Sutureless Valve

August 05, 2015

News Industry News

First Aortic Valve Procedure With Newly Approved Device Performed at NYU Langone

July 29, 2015

News Industry News

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

July 22, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Daily News

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Industry News

New Procedure at Dominican Hospital Allows for Heart Valve Replacement Without Opening Chest

June 24, 2015

News Industry News

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

June 23, 2015

News Industry News

CardiAQ™ Valve Technologies reports first-in-human percutaneous transfemoral, transseptal implantation with its second generation transcatheter bioprosthetic mitral heart valve

June 23, 2015

News Daily News

Moderate-to-Severe Mitral Regurgitation Signals Elevated Mortality Risk After TAVR

Todd Neale

June 18, 2015

Advertisement

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR

Subanálisis del Ensayo CoreValve norteamericano: Solo la TAVR Femoral Ofrece una Ventaja en la Calidad de Vida Precoz sobre la Cirugía

CoreValve美国亚组分析：仅有股动脉TAVR表现出相对于外科手术的早期生活质量优势

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

Sorin Group Obtains Health Canada Approval for Perceval, Its Next Generation Sutureless Valve

First Aortic Valve Procedure With Newly Approved Device Performed at NYU Langone

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

MVARC Document Offers Template for Mitral Valve Therapeutics Research

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

New Procedure at Dominican Hospital Allows for Heart Valve Replacement Without Opening Chest

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

CardiAQ™ Valve Technologies reports first-in-human percutaneous transfemoral, transseptal implantation with its second generation transcatheter bioprosthetic mitral heart valve

Moderate-to-Severe Mitral Regurgitation Signals Elevated Mortality Risk After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content